166 related articles for article (PubMed ID: 36245843)
21. Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer.
Xie LY; Huang HY; Hao YL; Yu M; Zhang W; Wei E; Gao C; Wang C; Zeng L
Front Genet; 2023; 14():1067172. PubMed ID: 37007952
[No Abstract] [Full Text] [Related]
22. Alternations of gene expression in PI3K and AR pathways and DNA methylation features contribute to metastasis of prostate cancer.
Zhao Y; Hu X; Yu H; Liu X; Sun H; Shao C
Cell Mol Life Sci; 2022 Jul; 79(8):436. PubMed ID: 35864178
[TBL] [Abstract][Full Text] [Related]
23. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
[TBL] [Abstract][Full Text] [Related]
24. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
[TBL] [Abstract][Full Text] [Related]
25. [Identification and validation of hub genes in prostate cancer progression based on weighted gene co-expression network analysis].
Zhang H; Chen N; Wang X; Gao B; Ling M; Chen G; Wu Z; Li Y; Zhong W; Pan B
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1631-1640. PubMed ID: 34916188
[TBL] [Abstract][Full Text] [Related]
26. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
Zhao Y; Tao Z; Li L; Zheng J; Chen X
BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
[TBL] [Abstract][Full Text] [Related]
27. Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
Wang L; Liu X; Liu Z; Wang Y; Fan M; Yin J; Zhang Y; Ma Y; Luo J; Li R; Zhao X; Zhang P; Zhao L; Fan J; Chen Y; Lu W; Song X
Sci Rep; 2022 Jan; 12(1):192. PubMed ID: 34996995
[TBL] [Abstract][Full Text] [Related]
28. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract][Full Text] [Related]
30. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
31. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer.
Mu HQ; Liang ZQ; Xie QP; Han W; Yang S; Wang SB; Zhao C; Cao YM; He YH; Chen J
Biomark Med; 2020 Apr; 14(5):353-369. PubMed ID: 32253914
[No Abstract] [Full Text] [Related]
33. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
Rui X; Shao S; Wang L; Leng J
BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
[TBL] [Abstract][Full Text] [Related]
34. Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?
Carozzi F; Tamburrino L; Bisanzi S; Marchiani S; Paglierani M; Di Lollo S; Crocetti E; Buzzoni C; Burroni E; Greco L; Baldi E; Sani C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):201-12. PubMed ID: 26210155
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Hu X; Sun G; Shi Z; Ni H; Jiang S
PeerJ; 2020; 8():e8505. PubMed ID: 32117620
[TBL] [Abstract][Full Text] [Related]
36. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.
Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Ma Z; Xu J; Ru L; Zhu W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
[TBL] [Abstract][Full Text] [Related]
39. Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
Cai J; Chen Z; Chen X; Huang H; Lin X; Miao B
Biomed Res Int; 2020; 2020():4264291. PubMed ID: 32953881
[TBL] [Abstract][Full Text] [Related]
40. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
